Clare Hammond

Clare Hammond has a diverse work experience spanning various roles and companies. Clare began their career in 2002 at AstraZeneca as a Scientist and Bioanalyst, eventually transitioning to a Senior Scientist and Bioanalyst and then a Functional Project Leader & Senior Scientist. Clare's responsibilities included conducting and interpreting pre-clinical in vivo study data, acting as a DMPK consultant, and designing and reporting pre-clinical studies. In 2012, Clare worked as a Software Implementation Manager at New Horizons Snorkel and Dive Centre, where they implemented a novel software system and conducted training and marketing activities. Clare then joined Covance in 2013 as an In Vitro Metabolism Study Director, where they participated in client meetings and ensured study designs met regulatory requirements. From 2015 to 2020, Clare co-founded and co-directed In Vivo Assays (Limited), a CRO specializing in offering DMPK and ADME in vivo assays. Currently, they work at Sygnature Discovery as a Lead Scientist.

Clare Hammond completed their Bachelor of Science (BSc) in Biochemistry with Medical Biochemistry at the University of Leeds from 1998 to 2002. Clare also received additional certifications, including being an Instructor and a PADI Dive Master from PADI, obtaining their Emergency First Response certification in December 2013, and achieving a Lean Sigma Green Belt from Smallpeice Enterprises Ltd in 2011. Clare's earlier education history is not provided in the information given.